The Korean Research-based Pharmaceutical Industry Association (KRPIA), which represents the multinational pharmaceutical companies that are considered the key source for the supply of new drugs, welcomed a new leader last February.

KRPIA’s newly appointed Chairman Dong-Wook Oh (51) has been leading Pfizer Pharmaceuticals Korea since 2015. Oh's appointment has brought on various changes within the organization.

For the first time in three years, KPRIA has appointed a Korean to head its organization. Demand for the appointment of a Korean leader had been rising as it would enable better communication with relevant ministries, as the access and supply of new drugs is the primary o